Literature DB >> 20173028

Modulation of T lymphocyte function by the pregnane X receptor.

Sandrine Dubrac1, Andreas Elentner, Susanne Ebner, Jutta Horejs-Hoeck, Matthias Schmuth.   

Abstract

The pregnane X receptor (PXR) is a ligand-activated transcription factor regulating genes central to drug and hormone metabolism in the liver. Previous reports indicated that PXR is expressed in PBMC, but the role of PXR in immune cells remains unknown. In this paper, we report increased PXR expression in mouse and human T lymphocytes upon immune activation. Furthermore, pharmacologic activation of PXR inhibits T lymphocyte proliferation and anergizes T lymphocytes by decreasing the expression of CD25 and IFN-gamma and decreasing phosphorylated NF-kappaB and MEK1/2. Although these effects are preceded by an increase of suppressor of cytokine signaling 1, a master switch for IFN-gamma expression, in a PXR-dependent manner, T-bet expression remains unchanged. Conversely, PXR-deficient mice exhibit an exaggerated T lymphocyte proliferation and increased CD25 expression. Furthermore, PXR-deficient lymphocytes produce more IFN-gamma and less of the anti-inflammatory cytokine IL-10. In summary, these results reveal a novel immune-regulatory role of PXR in T lymphocytes and identify suppressor of cytokine signaling 1 as an early signal in PXR-mediated T lymphocyte suppression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173028     DOI: 10.4049/jimmunol.0902151

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

2.  RNA interference screen identifies NAA10 as a regulator of PXR transcription.

Authors:  Peter O Oladimeji; William C Wright; Jing Wu; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2018-12-16       Impact factor: 5.858

Review 3.  Novel functions of PXR in cardiometabolic disease.

Authors:  Changcheng Zhou
Journal:  Biochim Biophys Acta       Date:  2016-02-26

Review 4.  Pregnane X receptor as a target for treatment of inflammatory bowel disorders.

Authors:  Jie Cheng; Yatrik M Shah; Frank J Gonzalez
Journal:  Trends Pharmacol Sci       Date:  2012-05-18       Impact factor: 14.819

5.  Deficiency of PXR decreases atherosclerosis in apoE-deficient mice.

Authors:  Yipeng Sui; Jinxian Xu; Jennifer Rios-Pilier; Changcheng Zhou
Journal:  J Lipid Res       Date:  2011-06-18       Impact factor: 5.922

Review 6.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Authors:  Bryan Mackowiak; Jessica Hodge; Sydney Stern; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2018-05-14       Impact factor: 3.922

Review 7.  PXR: More Than Just a Master Xenobiotic Receptor.

Authors:  Peter O Oladimeji; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2017-11-07       Impact factor: 4.436

Review 8.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

Review 9.  The pregnane X receptor in tuberculosis therapeutics.

Authors:  Amina I Shehu; Guangming Li; Wen Xie; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-05       Impact factor: 4.481

10.  Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice.

Authors:  Yipeng Sui; Zhaojie Meng; Se-Hyung Park; Weiwei Lu; Christopher Livelo; Qi Chen; Tong Zhou; Changcheng Zhou
Journal:  J Lipid Res       Date:  2020-03-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.